Page 5 - Evercore Group News Today

SAN CARLOS, Calif., Jan. 30, 2024 -- Vaxcyte, Inc. , a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases,...

BRISBANE, Calif., Jan. 29, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious...

BRISBANE, Calif., Jan. 29, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious...

A federal judge in Delaware on Wednesday allowed an additional creditor to seek proceeds from an auction of shares in a parent of Citgo Petroleum, which could lead to an ownership change of the...

Dozens of companies have rushed in recent weeks to obtain data and join a U.S. court-ordered auction of shares in a parent of Houston-based oil refiner Citgo Petroleum, Venezuela's foreign crown jewel, according to people familiar with the matter, as a first-round bidding is set to close on Monday. The sale, expected to be one of the largest U.S. court auctions, was launched in October by a Delaware judge to settle a long-running legal battle against Venezuela for expropriations and mounti...

The latest oil and gas news, dedicated to all things oil and gas: people, technologies, transactions, trends, and macro-economic analysis that impact commodity prices.

LifeLabs has drawn multiple bidders and two health care companies have emerged as the leading contenders, sources say

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

Audacy entered into a restructuring support agreement with a supermajority of its debtholders on the terms of a comprehensive restructuring that will significantly deleverage its balance sheet and further position Audacy for long-term growth. Through the restructuring, Audacy and its debtholders will undertake a deleveraging transaction to equitize...

Johnson & Johnson and Merck on Monday announced plans to buy cancer therapy developers on the first day of a major U.S. healthcare conference, igniting what industry participants hope will be a strong...